Xeno Transplants Corp. operates as a bio-technology research and development company. The company is headquartered in Vancouver, British Columbia and currently employs 0 full-time employees. The company went IPO on 2006-08-01. Xenotransplantation is defined as the transplantation of organs, cells and tissues from one species to another. The firm has one reportable segment, which is the development of products to address the shortage of human donor cells and organs for transplantation into patients. All the Company’s activities are located in the United States. The firm intends to develop therapeutic applications of organs and cells derived from genetically engineered pigs as a transplant alternative to limited human donor sources.
XENO stock price ended at $0 on 火曜日, after rising NaN%
On the latest trading day Dec 30, 2025, the stock price of XENO rose by NaN%, climbing from $0.00 to $0.00. Throughout the session, the stock experienced a volatility of NaN%, with prices fluctuating between a daily low of $0.00 and a high of $0.00. Alongside this price increase, trading volume also rose by 7.1K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 50.0K shares were traded, amounting to a market value of approximately --.
ポートフォリオ